Cytodyn Inc (CYDY)

[LongTkt]

Global Market Size vs. Leronlimab Treatment Disease List

I put this bit of research together for consideration.

Easy to Quantify Global Market Size
$78.3B Diabetes (type 1 and 2)
$40.4B Allergies (anaphylactic shock)
$33.0B Asthma
$30.8B Multiple Sclerosis
$25.8B HIV
$19.8B COPD
$19.8B Emphysema
$17.7B Alzheimer's
$17.6B Sjogren’s Syndrome
$13.4B Inflammatory Bowel Disease/Colitis/Crohn's Disease
$10.5B Atherosclerosis
$10.0B Atopic Dermatitis
$8.4B Parkinson's Disease
$8.3B NASH
$7.0B Pneumonia
$3.2B Neurofibromatosis
$2.9B Duchenne Muscular Dystrophy/Polymyositis (possibly other muscular dystrophies also)
$1.1B Lupus
$0.9B Dermatomyositis
$0.9B Grave’s Disease/Hashimoto’s Thyroiditis (US Only)
$0.9B Scleroderma
$0.9B Tuberculosis
$0.7B Coeliac Disease
$0.7B Psoriasis
$0.6B Guillain-Barre Syndrome
$0.6B GVHD
$0.5B Myasthenia Gravis
$0.4B Idiopathic Pulmonary Fibrosis
$0.4B Rheumatoid Arthritis
$0.4B Vasculitis
$0.2B Sarcoidosis
$0.2B Chronic Fatigue Syndrome
$0.1B Bullous diseases (Pemphigus)
$0.1B Lambert-Eaton Syndrome
===========
$356B Sub-Total

$1,316.9B COVID-19

Difficult to Quantify Market Sizes
$?.?B Chronic Kidney Disease (underlying pathologies)
$?.?B Fibromyalgia
$?.?B Cancer (20+ types)
$?.?B Hepatitis (autoimmune)
$?.?B Influenza (severe)
$?.?B Kawasaki Syndrome
$?.?B Marshall’s syndrome (PFAPA)
$?.?B Myocarditis
$?.?B Post-Myocardial Infarction Syndrome
$?.?B Rheumatic Fever
$?.?B Sickle Cell Disease (anti-inflammatory effect)
$?.?B Stroke